Clinical outcomes
| Median overall survival, all patients (months, range) Total 1 year survival | n = 13 14.3 (0.2 – 72.6) 17 (56.7%) |
| Median overall survival, patients treated with complete surgical resection (months, range) Total 1 year survival | n = 13 37.0 (12.1 – 72.6) 13 (100%) |
| Median overall survival, patients without resection or with uncomplete resection of tumor (months, range) Total 1 year survival | n = 17 2.2 (0.2 – 60.0) 3 (17.6%) |
| Median overall survival, patients treated with radiation (months, range) Total 1 year survival | n = 7 24.8 (7.1 – 35.8) 6 (85.7%) |
| Median overall survival, patients treated with immunotherapy (months, range) Total 1 year survival | n = 18 23.7 (0.6 – 66.2) 16 (88.9%) |
| Median overall survival, patients treated with complete surgical resection and immunotherapy (months, range) Total 1 year survival | n = 11 35.0 (12.1 – 66.2) 11 (100%) |
| Median overall survival, patients treated with complete surgical resection, radiation therapy, and immunotherapy (months, range) Total 1 year survival | |
| Median overall survival, by anatomic site of metastases (months, range) M1a - All lymph node/soft tissue/muscle (15 pts, 50%) M1b – Lung (1 pt, 3.3%) M1c – Visceral (8 pts, 26.7%) M1d – Brain (6 pts, 20%) | Outcome by anatomic site 32.0 (1.4 – 72.6) 10.3 (10.3–10.3) 1.5 (0.2 – 60.0) 6.2 (1 – 35.8) |
| Median overall survival, by # of metastases (months, range) 1–3 (n = 18) Total 1 year survival 4+ (n = 12) Total 1 year survival | Outcome by # of mets 26.1 (0.6 – 72.6) 15 (83.3%) 2.4 (0.2 – 60.0) 3 (25%) |
| Median overall survival, by # of organs involved (months, range) 1 organ (n = 16) Total 1 year survival 2+ organs (n = 14) Total 1 year survival | Outcome by # of organs involved 23.7 (1.4 – 72.6) 14 (87.5%) 2.2 (0.2 – 60.0) 4 (28.6%) |
| Median overall survival, by size of largest metastases (months, range) Total 1 year survival 2–5 cm (n = 12) Total 1 year survival >5 cm (n = 12) Total 1 year survival | Outcome by size of largest met 11.4 (1.0 – 51.77) 3 (50%) 30.9 (0.3 – 66.2) 7 (58.3%) 10.9 (0.2 – 72.6) 8 (66.7%) |